Clinical Trial Update: Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of donepezil hydrochloride for attention impairment in preadolescent and adolescent cancer-treated patients; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit After Cancer Treatment
• Attention Impairment

Drugs mentioned

• Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

Sponsor: Eisai Inc. | Conditions: Attention Impairment | Phase 3 | Status: COMPLETED | Results posted: 2020-03-27